HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 31.0507

Change

-0.02 (-0.05)%

Market Cap

USD 0.14B

Volume

411.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.04 (-0.20%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.24 (+0.43%)

USD 33.74B
DFAC Dimensional U.S. Core Equity 2..

+0.02 (+0.06%)

USD 28.49B
DTB DTB

+0.11 (+0.56%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 24.34B
GBTC Grayscale Bitcoin Trust (BTC)

-3.51 (-6.54%)

USD 23.75B
SGOV iShares® 0-3 Month Treasury B..

+0.04 (+0.04%)

USD 22.81B
AVUV Avantis® U.S. Small Cap Value..

-1.35 (-1.51%)

USD 11.35B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 10.62B
DFUV Dimensional US Marketwide Valu..

-0.21 (-0.54%)

USD 10.39B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.13% 60% D- 64% D
Dividend Return 0.83% 31% F 24% F
Total Return 6.96% 59% D- 60% D-
Trailing 12 Months  
Capital Gain 10.48% 60% D- 63% D
Dividend Return 0.86% 14% F 10% F
Total Return 11.34% 57% F 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.53% 66% D+ 49% F
Dividend Return 2.40% 64% D 41% F
Total Return 0.86% 37% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 7.02% 59% D- 83% B
Risk Adjusted Return 34.12% 65% D 57% F
Market Capitalization 0.14B 68% D+ 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.